References

Bennett D, Morton C. A study of owner observed behavioural and lifestyle changes in cats with musculoskeletal disease before and after analgesic. J Feline Med Surg. 2009; 11:997-1004 https://doi.org/10.1016/j.jfms.2009.09.016

Metacam®. 2021. https://www.metacam.co.uk/ (accessed 25 October 2021)

Budsberg SC, Torres BT, Kleine SA, Sandberg GS, Berieski AK. Lack of effectiveness of tramadol hydrochloride for the treatment of pain and joint dysfunction in dogs with chronic osteoarthritis. J Am Vet Med Assoc. 2018; 252:(4)427-432 https://doi.org/10.2460/javma.252.4.427

Clarke SP, Mellor D, Clements DN, Gemmill T, Farrell M, Carmichael S, Bennett D. Prevalence of radiographic signs of degenerative joint disease in a hospital population of cats. Vet Record. 2005; 157:(25)793-799 https://doi.org/10.1136/vr.157.25.793

Drum MG, Bockstahler B, Levine D, Marcellin-Little DJ. Feline rehabilitation. Vet Clin North Am Small Anim Pract. 2015; 45:(1)185-201 https://doi.org/10.1016/j.cvsm.2014.09.010

Enomoto M, Mantyk PW, Murrell J, Innes JF, Lascelles BDX. Anti-nerve growth factor monoclonal antibodies for the control of pain in dogs and cats. Vet Record. 2019; 184:(1) https://doi.org/10.1136/vr.104590

Godfrey DR Osteoarthritis in cats: a retrospective radiological study. J Small Anim Pract. 2005; 46:425-429 https://doi.org/10.1111/j.1748-5827.2005.tb00340.x

Gruen ME, Myers JAE, Lascelles BDX. Efficacy and safety of an anti-nerve growth factor antibody (frunevetmab) for the treatment of degenerative joint disease-associated chronic pain in cats: a multisite pilot field study. Front Vet Sci. 2021; 8 https://doi.org/10.3389/fvets.2021.610028

Guedes AGP, Meadows JM, Pypendop BH, Johnson EG. Evaluation of tramadol for treatment of osteoarthritis in geriatric cats. J Am Vet Med Assoc. 2018a; 252:(5)565-571 https://doi.org/10.2460/javma.252.5.565

Guedes AGP, Meadows JM, Pypendop BH, Johnson EG, Zaffarano B. Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impairment and quality of life in osteoarthritic geriatric cats. J Am Vet Med Assoc. 2018b; 253:(5)579-585 https://doi.org/10.2460/javma.253.5.579

Guillot M, Moreau M, Heit M, Martel-Pelletier J, Pelletier JP, Troncy E. Characterization of osteoarthritis in cats and meloxicam efficacy using objective chronic pain evaluation tools. 2013; 196:(3)360-367 https://doi.org/10.1016/j.tvjl.2013.01.009

Gunew MN, Menrath VH, Marshall RD. Long-term safety, efficacy and palatability of oral meloxicam at 0.01–0.03 mg/kg for treatment of osteo-arthritic pain in cats. J Feline Med Surg. 2008; 10:(3)235-241 https://doi.org/10.1016/j.jfms.2007.10.007

Hardie EM, Roe SC, Martin FR. Radiographic evidence of degenerative joint disease in geriatric cats: 100 cases (1994-1997). J Am Vet Med Assoc. 2002; 628-632 https://doi.org/10.2460/javma.2002.220.628

Johnson KA, Lee AH, Swanson KS. Nutrition and nutraceuticals in the changing management of osteoarthritis for dogs and cats. J Am Vet Med Assoc. 2020; 256:(12)1335-1341 https://doi.org/10.2460/javma.256.12.1335

King JN, King S, Budsberg SC Clinical safety of robenacoxib in feline osteoarthritis: results of a randomized, blinded, placebo-controlled clinical trial. J Feline Med Surg. 2016; 18:(8)632-642 https://doi.org/10.1177/1098612X15590870

Kongara K, Chambers JP. Robenacoxib in the treatment of pain in cats and dogs: safety, efficacy, and place in therapy. Vet Med. 2018; 15:(9)53-61 https://doi.org/10.2147/VMRR.S170893

KuKanich K, George C, Roush JK Effects of low-dose meloxicam in cats with chronic kidney disease. J Feline Med Surg. 2021; 23:(2)138-148 https://doi.org/10.1177/1098612X20935750

Lascelles BDX. Feline degenerative joint disease. Vet Surg. 2010; 39:(1)2-13 https://doi.org/https://doi.org/10.1111/j.1532-950X.2009.00597.x

Lascelles BDX, Dong YH, Marcellin-Little DJ, Thomson A, Wheeler S, Correa M. Relationship of orthopedic examination, goniometric measurements, and radiographic signs of degenerative joint disease in cats. BMC Vet Res. 2012; 8:(1) https://doi.org/10.1186/1746-6148-8-10

Ley C, Ramer G, Leijon A, Ley CJ. Acetabular margin changes in feline hip joints – implications for radiologic diagnosis and development of osteoarthritis. Res Vet Sci. 2021; 137:243-251 https://doi.org/10.1016/j.rvsc.2021.05.010

Marshall WG, Hazewinkel HA, Mullen D, Meyer G, Baert K, Carmichael S. The effect of weight loss on lameness in obese dogs with osteoarthritis. Veterinary Reseach Communications. 2010; 34:241-253 https://doi.org/10.1007/s11259-010-9348-7

Richardson DC, Schoenherr WD, Zicker SC. Nutritional management of osteoarthritis. Vet Clin North Am Small Anim. 1997; 27:883-911 https://doi.org/10.1016/S0195-5616(97)50085-4

Shipley H, Flynn K, Tucker L Owner evaluation of quality of life and mobility in osteoarthritic cats treated with amantadine or placebo. J Feline Med Surg. 2021; 23:(6)568-574 https://doi.org/10.1177/1098612X20967639

Slingerland LI, Hazewinkel HAW, Meij BP, Picavet PH, Voorhoot G. Cross-sectional study of the prevalence and clinical features of osteoarthritis in 100 cats. Vet J. 2011; 187:(3)304-309 https://doi.org/10.1016/j.tvjl.2009.12.014

Veterinary management of feline osteoarthritis

02 November 2021
8 mins read
Volume 12 · Issue 9
Figure 2. Acupuncture is often well-tolerated by cats and may help alleviate chronic pain.
Table 1. Behavioural, examination and radiographic changes (which may be seen as a result of osteoarthritis in the feline)

Abstract

Osteoarthritis is a progressive, degenerative condition, which causes mobility issues and behavioural changes in affected cats as a result of chronic pain. Despite reports in the literature suggesting a vast prevalence of the condition among the domestic cat population, the condition appears to be underdiagnosed. This is likely due to a combination of subtle clinical signs, lack of owner awareness and poor correlation between radiographical changes and severity of clinical signs. Multimodal management of feline osteoarthritis is likely to be most successful in alleviating pain and improving quality of life. This may include some or all of the following: medical management, rehabilitation therapies, weight loss, environmental adaptations, joint supplements and surgery.

Osteoarthritis (OA) is a progressive and multi-factorial degenerative joint disease (Enomoto et al, 2019; Ley et al, 2021). The disease affects multiple structures within the joint leading to destruction of the articular cartilage layer, changes within the subchondral bone, osteophyte formation and inflammation of the synovial membrane (Ley et al, 2021).

The aetiology of feline OA is different to that of canine OA. There is much less evidence to support OA secondary to developmental disease processes such as dysplasia, with one particular study citing this to be just 13% (Godfrey, 2005). Another study indicated that around 25% of cases of feline OA can be attributed to trauma (Clarke et al, 2005). The remaining cases may be idiopathic, primary, immunemediated, bacterial or have a genetic component, such as osteochondrodysplasia affecting the Scottish Fold (Lascelles, 2010). The most common joints affected in the feline patient are the hip, stifle, hock and elbow (Lascelles, 2010).

Register now to continue reading

Thank you for visiting The Veterinary Nurse and reading some of our peer-reviewed content for veterinary professionals. To continue reading this article, please register today.